Ciprofloxacin for the Treatment of Uncomplicated Gonorrhea Infection in Adolescents: Does the Benefit Outweigh the Risk?

Ciprofloxacin for the Treatment of Uncomplicated Gonorrhea Infection in Adolescents: Does the Benefit Outweigh the Risk?

The highest rates of reported gonorrhea infections occur among adolescent females aged 15–19 years. Among the Centers for Disease Control and Prevention (CDC)–recommended single-dose gonorrhea treatment regimens, ciprofloxacin, a fluoroquinolone antibiotic, is approximately half the cost of other CD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2002-10, Vol.35 (Supplement-2), p.S191-S199
Hauptverfasser: Burstein, Gale R., Berman, Stuart M., Blumer, Jeffery L., Moran, John S.
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adolescents
Anti-Infective Agents - adverse effects
Anti-Infective Agents - therapeutic use
Arthralgia
Cartilage
Ciprofloxacin - adverse effects
Ciprofloxacin - therapeutic use
Cystic fibrosis
Dosage
Fluoroquinolones
Gonorrhea
Gonorrhea - drug therapy
Gonorrhea - economics
Gonorrhea - pathology
Humans
Infections
Pediatrics
Quinolones
Risk Assessment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The highest rates of reported gonorrhea infections occur among adolescent females aged 15–19 years. Among the Centers for Disease Control and Prevention (CDC)–recommended single-dose gonorrhea treatment regimens, ciprofloxacin, a fluoroquinolone antibiotic, is approximately half the cost of other CDC-recommended oral treatment regimens. Fluoroquinolone use in patients aged
ISSN:1058-4838
1537-6591
DOI:10.1086/342107